Ethyl 2-Bromo-5-Thiazolecarboxylate

Ethyl 2-bromo-5-thiazolecarboxylate (CAS 105300-38-7) constitutes a halogenated heterocyclic building block with a molecular formula of C₆H₆BrNO₂S and a relative molecular mass of 236.09. The compound is handled as a clear, pale yellow to amber liquid with a density of approximately 1.58 g/mL at 20 °C and a refractive index n₂₀/D around 1.562. In the supply chain for drug discovery and crop protection research, it serves as a dual electrophilic platform: the bromine atom at ring position 2 undergoes oxidative addition with palladium(0) catalysts, while the ethyl ester at position 5 can be hydrolyzed, reduced, or transformed into amides and hydrazides. A typical release specification from qualified contract manufacturers requires an assay of ≥98.0% by GC (FID, area‑%, DB‑5 column, 30 m × 0.25 mm ID, 0.25 µm film) and ≤0.5% total related substances, with water content held below 500 ppm by Karl Fischer titration because residual moisture promotes ester saponification during storage.

How Does Substitution Pattern Influence Cross‑Coupling Efficiency?

The regiochemical arrangement of bromine and carboxylate functionalities on the thiazole ring dictates both catalytic turnover and byproduct profiles. In the 2‑bromo‑5‑carboxylate isomer, the carbon–bromine bond is flanked by an electron‑withdrawing ester substituent at the 5‑position and a ring sulfur atom; this activates the C–Br bond toward oxidative addition on Pd(dppf)Cl₂ or Pd(PPh₃)₄ without generating the steric congestion observed in 4‑bromo analogs. Head‑to‑head Suzuki–Miyaura couplings with phenylboronic acid (1.2 equiv) run in degassed THF/H₂O (4:1) at 60 °C in the presence of 2.0 mol% Pd(dppf)Cl₂ and 2.0 equiv of K₂CO₃ illustrate the contrast:

Thiazole Ester Substrate	Conversion after 2 h (%)	Isolated Yield (%)	Observations
Ethyl 2‑bromo‑5‑thiazolecarboxylate	98	85	No homocoupling detected by HPLC at 254 nm
Ethyl 2‑chloro‑5‑thiazolecarboxylate	22	18	Requires 80 °C and 5 mol% catalyst; significant proto‑debromination
Ethyl 2‑bromo‑4‑thiazolecarboxylate	76	68	Compromise between steric shielding and electronic activation

The bromine atom in the 5‑position of the alternative regioisomer (ethyl 5‑bromo‑2‑thiazolecarboxylate) is substantially less reactive because the ester withdraws electron density from the ring at the adjacent 2‑position, deactivating the C–Br bond; coupling there typically demands elevated temperatures (90–100 °C) and prolonged reaction times exceeding 12 h. Thus, the 2‑bromo‑5‑carboxylate arrangement is the enabling regioisomer when molecular complexity must be installed rapidly under mild conditions, a priority in library synthesis where functional‑group tolerance is critical. Without a header, the discussion naturally transitions into the significance of the ethyl ester moiety itself. In kilogram‑scale preparations of active pharmaceutical ingredients, the choice between methyl, ethyl, and tert‑butyl esters is not trivial. Methyl 2‑bromo‑5‑thiazolecarboxylate (CAS 954239-19-1) is a crystalline solid, which simplifies purification by recrystallization from heptane/EtOAc mixtures, but its higher solubility in aqueous basic media creates losses during extractive workup. The ethyl ester strikes a practical balance: sufficient lipophilicity to partition cleanly into organic phases (log P approximately 1.8) while remaining amenable to mild base‑catalyzed hydrolysis with LiOH in THF/water at 0–5 °C without substantial epimerization of adjacent chiral centers. Swapping the ester for a tert‑butyl protective group complicates downstream deprotection because the thiazole ring can undergo acid‑catalyzed ring‑opening if TFA is used neat at room temperature; this side reaction is suppressed only when the deprotection is executed in dichloromethane at −10 °C with ≤5% v/v TFA—a processing constraint that plant engineering records from a European CDMO indicate extends cycle time by 6–8 h per batch.

When the 2‑Bromo Isomer Outperforms Chlorinated Analogs in Late‑Stage Functionalization

A recurrent bottleneck in medicinal chemistry is late‑stage diversification of a penultimate intermediate bearing multiple heterocycles. The 2‑bromo‑5‑thiazolecarboxylate provides superior selectivity in Buchwald–Hartwig aminations because the oxidative addition step does not require the strongly donating, electron‑rich phosphine ligands that inevitably lead to catalyst deactivation by the thiazole nitrogen. Using BrettPhos Pd G3 (1.5 mol%) and NaOtBu in dioxane at 70 °C, primary and secondary amines couple with isolated yields consistently above 75%, whereas the chloro congener stagnates below 30% conversion under identical conditions. In a published kilogram‑scale process for a FAAH inhibitor, the development team abandoned the chloro ester after three campaigns because the heterogeneous reaction mixture caused erratic heat‑transfer behavior in a 200 L glass‑lined reactor; the bromo substrate, fully soluble at the reaction temperature, enabled reproducible heating profiles and suppressed localized hot spots that had previously generated 3–5% of a dimeric impurity (identified as 5,5′‑bis(ethoxycarbonyl)‑2,2′‑bithiazole). This dimer arises from competing homo‑coupling when the oxidative addition complex persists in the absence of rapid nucleophile binding, and its formation rate is roughly 0.07% per hour for the 2‑bromo derivative versus 0.02% per hour for the 2‑chloro—the counterintuitive reversal explained by the longer lifetime of the Pd(II) intermediate in the sluggish oxidative addition of the chloro substrate. Storage stability dictates inventory management in a synthetic laboratory. The compound should be kept under argon in amber glass bottles at 2–8 °C. Exposure to ambient humidity over multiple openings leads to hydrolytic degradation; after 30 cap‑on‑cap‑off cycles in a climate‑controlled warehouse (25 °C, 60% RH), GC area purity dropped from 99.1% to 95.7%, with 2‑bromo‑5‑thiazolecarboxylic acid emerging as the principal impurity. Bulk shipments in HDPE pails are therefore furnished under nitrogen headspace, and retest dating is assigned at 12 months from the date of manufacture when storage conditions are verified. For material intended for GMP intermediate production, a forced‑degradation study performed in accordance with ICH Q1A(R2) guidelines confirms sensitivity toward light (photolytic debromination under ICH Option 2 conditions) and oxidizing agents; contact with hydrogen peroxide or meta‑chloroperbenzoic acid must be avoided as ring sulfoxidation competes with N‑oxide formation, leading to a complex mixture that challenges preparative chromatography.

Purification Bottlenecks at Kilo‑Lab and Pilot Scale

Vacuum distillation offers the most robust purification pathway for the technical‑grade material. The boiling point of 84–87 °C at 0.3 mbar (reported on a Buchi Kugelrohr apparatus) climbs to 105–108 °C at 1.5 mbar in a wiped‑film evaporator with a jacket temperature set point of 120 °C. Thermal decomposition releases HBr, which contaminates the distillate with acidic aerosols unless a cold trap charged with solid KOH pellets is inserted between the distillation head and the rotary‑vane pump. In a 50 L fraction‑cut distillation performed with a Pope 4‑inch wiped‑film still, operators observed that when the feed rate exceeded 1.2 kg/h, the condenser surface temperature rose above 15 °C and the vacuum level degraded to 2.5 mbar, elevating the pot residue and reducing the yield of the heart cut from 92% to 78%. An alternative strategy—silica gel chromatography with ethyl acetate/heptane (1:9)—is routinely employed at 100–500 g scale but becomes logistically prohibitive beyond 5 kg because the product tailing factor on irregular silica (60 Å, 40–63 µm) requires 15 kg of stationary phase per kilogram of crude, a process that generates 25 L of mixed solvent waste per batch and extends total cycle time beyond 10 h when column conditioning and fraction pooling are included. Where purification by recrystallization is attempted following ester hydrolysis to the carboxylic acid, the crystallized acid can be re‑esterified under Fischer–Speier conditions. This two‑step sequence—saponification with 2.0 equiv of NaOH in aqueous ethanol, precipitation of the acid by pH adjustment to 2.5 with HCl, and esterification in ethanol with H₂SO₄ catalysis—raises the overall purity to 99.5% (HPLC at 220 nm) but at the expense of a 20% mass loss across the cycle. The process is nevertheless employed when the downstream Heck coupling requires a palladium scavenger‑free substrate; metal residue analysis by ICP‑MS shows that the distillation‑purified product can retain 12–25 ppm of iron from stainless‑steel contact, whereas the crystalline acid route reduces iron content below 5 ppm, meeting the <10 ppm specification demanded by several pharmaceutical end‑users.

Parameter	Typical Value	Test Method
Appearance	Clear, pale yellow liquid	Visual inspection against white background
Assay (GC)	≥98.5%	In‑house method GC‑FID, HP‑5 capillary column, 30 m
Water content	≤300 ppm	Karl Fischer coulometry (Metrohm 831 KF)
Individual impurity	≤0.3%	GC/LC, any unidentified peak
pH of aqueous extract	5.0–7.0	pH meter, 10% suspension in CO₂‑free water
Residue on ignition	≤0.1%	USP <281>

Interacting with base‑sensitive functional groups in a complex target molecule demands precise control over transesterification risk. When ethyl 2‑bromo‑5‑thiazolecarboxylate is treated with an alcohol in the presence of a catalytic amount of Ti(OiPr)₄, ester exchange proceeds to the corresponding alkyl ester without dehalogenation, a finding leveraged to install bulky esters for prodrug strategies. However, amine bases such as DBU or TMG promote a competing elimination pathway that releases ethylene and forms the carboxylate salt; this reaction becomes dominant at temperatures above 50 °C and precludes the use of these bases as acid scavengers in amidation protocols. Process chemists therefore select N‑methylmorpholine or inorganic carbonates with a pKa difference carefully matched to avoid unintended cleavage.

If Regiochemical Purity Exceeds 99.5%, Downstream Crystallization Yields Improve

Isomeric contamination is an underappreciated source of batch failure in pilot plants. The synthetic route from thiazole‑5‑carboxylic acid via direct bromination with Br₂ in acetic acid generates roughly 2–4% of the 4‑bromo isomer, which co‑distills with the desired product and mimics its retention time on standard GC columns. Failure to quantify this isomer by a dedicated isocratic HPLC method (C18, 250 mm × 4.6 mm, acetonitrile/0.1% TFA in water 55:45) has led to at least one recorded incident where a final active pharmaceutical ingredient failed XRPD identity because the incorporated isomeric impurity disrupted crystal packing, lowering the melting point by 8 °C and broadening the DSC endotherm beyond the acceptance window. Manufacturers now routinely supply a certificate of analysis that includes a “regioisomeric purity” entry, with an acceptance criterion of ≥99.0% for the 2‑bromo‑5‑isomer by HPLC peak area. In comparison with other 2‑brominated heterocyclic esters—such as ethyl 2‑bromopyridine‑3‑carboxylate or ethyl 2‑bromofuran‑5‑carboxylate—the thiazole scaffold introduces an additional coordination site through the ring sulfur, which can transiently bind palladium and modulate catalytic cycles. This subtle effect is visible in Negishi couplings where the organozinc reagent is generated from 2‑bromo‑5‑thiazolecarboxylate using zinc dust activated with 1,2‑dibromoethane and TMSCl in DMA; the resulting zincate, when coupled to aryl iodides under Pd₂(dba)₃/SPhos, delivers cross‑coupled products in yields that are 10–15% higher than those obtained from the analogous pyridine or furan esters under an identical protocol. The difference is attributed to a stabilization of the Pd–thiazole π‑complex that retards β‑hydride elimination from the alkyl ligand. Practitioners exploiting this reactivity in parallel synthesis routinely pre‑activate the zinc reagent at 45 °C for 1 h and avoid any solvent swap that would introduce residual water, as the resulting organozinc hydrolysis regenerates the debrominated ester, a near‑isobaric impurity that co‑elutes on reverse‑phase HPLC. For those evaluating ethyl 2‑bromo‑5‑thiazolecarboxylate against its non‑halogenated counterpart ethyl thiazole‑5‑carboxylate, the difference is stark: the latter demands directed ortho‑metalation with LDA or LiTMP at −78 °C to install an electrophile, a sequence that is incompatible with ketone or aldehyde functionalities present in the broader synthetic intermediate. The pre‑installed bromine therefore converts what would be a multi‑step, cryogenic synthesis into a room‑temperature cross‑coupling operation, a benefit directly reflected in the ≤0.5% of total process mass intensity allocated to cryogenic operations in the dozen commercial routes surveyed. Information on the chronic aquatic toxicity (OECD 201) and biodegradation (OECD 301B) of the substance remains sparse, but structural alerts for thiazole ring opening under environmental photolysis suggest that waste‑water treatment should include activated sludge acclimation before discharge.